Construction and clinical application of a human tissue-engineered epidermal membrane

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Dermatology

Background:

• Split-thickness skin graft donor sites thicker than 0.3 mm often experience prolonged healing and hypertrophic scarring.
• These complications present ongoing challenges for plastic surgeons.
• A human tissue-engineered epidermal membrane was developed to address these issues.

Purpose of the Study:

• To evaluate the efficacy of a human tissue-engineered epidermal membrane in promoting wound healing.
• To assess the membrane's ability to reduce hypertrophic scarring at skin graft donor sites.

Main Methods:

• An artificial allogenic epidermis was created using human keratinocytes and a chitosan-gelatin membrane.
• Split-thickness skin graft donor sites were divided into three groups: keratinocyte/chitosan-gelatin membrane, chitosan-gelatin membrane only (control), and petroleum jelly gauze (blank).
• Wound healing was assessed via gross observation, histological staining, and type I collagen analysis.

Main Results:

• The keratinocyte/chitosan-gelatin membrane group showed significantly reduced average healing time (8.1 days) compared to controls (16.4 days) and blank groups (22.9 days).
• The artificial epidermis demonstrated good survival and maintained normal structure.
• Less severe hypertrophic scar formation was observed in the treatment group.

Conclusions:

• In vitro constructed keratinocyte/chitosan-gelatin membranes can temporarily survive in vivo.
• These membranes effectively promote wound healing.
• The use of these membranes can reduce the severity of hypertrophic scarring in skin graft donor sites.